Natural killer cells as effectors of selection and differentiation of stem cells: Role in resolution of inflammation

Journal of Immunotoxicology

Volumn 11, Issue 4, 2014, Pages 297-307

  Jewett, Anahid ^a   Man, Yan Gao ^b,c   Cacalano, Nicholas ^d   Kos, Janko ^e   Tseng, Han Ching ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b Henry Jackson Foundation   (United States)

^c JILIN UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Apoptosis; Cancer stem cells; Differentiation; NF B; NK; Regulation

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; CD48 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LECTIN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MONOCLONAL ANTIBODY; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; SULINDAC; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

CANCER STEM CELL; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL SELECTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EMBRYONIC STEM CELL; EPITHELIUM CELL; EPITHELIUM TUMOR; GENE DELETION; GLIOBLASTOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MESENCHYMAL STEM CELL; MONOCYTE; MOUTH SQUAMOUS CELL CARCINOMA; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; REVIEW; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR; TUMOR MICROENVIRONMENT; TUMOR RESISTANCE; ANIMAL; CARCINOGENESIS; CYTOTOXICITY; IMMUNOLOGY; IMMUNOMODULATION; NEOPLASM; PHYSIOLOGY; REGENERATION; TUMOR ESCAPE; WOUND HEALING;

ANIMALS; CARCINOGENESIS; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOMODULATION; INFLAMMATION; KILLER CELLS, NATURAL; NEOPLASMS; NEOPLASTIC STEM CELLS; REGENERATION; STEM CELLS; TUMOR ESCAPE; WOUND HEALING;

EID: 84911476031     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.3109/1547691X.2013.877104     Document Type: Review

References (59)

1. Abdulkarim, B., Sabri, S., Deutsch, E., et al. 2002. Anti-viral agent Cidofovir restores p53 function and enhances radiosensitivity in HPVassociated cancers. Oncogene 21:2334-2346
2. Azzoni, L., Anegon, I., Calabretta, B., and Perussia, B. 1995. Ligand binding to FcgR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 154:491-499
3. Berlin, A. L., Paller, A. S., and Chan, L. S. 2002. Incontinentia pigmenti: A review and update on molecular basis of pathophysiology. J. Am. Acad. Dermatol. 47:169-187
4. Bonavida, B., Lebow, L. T., and Jewett, A. 1993. Natural killer cell subsets: Maturation, differentiation and regulation. Nat. Immunol. 12: 194-208
5. Chatenoud, L. 2003. CD3-specific antibody-induced active tolerance: From bench to bedside. Nat. Rev. Immunol. 3:123-132
6. Coffelt, S. B., Hughes, R., and Lewis, C. E. 2009. Tumor-Associated macrophages: Effectors of angiogenesis and tumor progression. Biochim. Biophys. Acta. 1796:11-18
7. Cooper, M. A., Fehniger, T. A., and Caligiuri, M. A. 2001. The biology of human NK cell subsets. Trends Immunol. 22:633-640
8. Deer, E. L., Gonzalez-Hernandez, J., Coursen, J. D., et al. 2010. Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 39:425-435
9. Dunn, G. P., Bruce, A. T., Ikeda, H., et al. 2002. Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol. 3:991-998
10. Dunn, G. P., Old, L. J., and Schreiber, R. D. 2004. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137-148
11. Farag, S. S., and Caligiuri, M. A. 2006. Human natural killer cell development and biology. Blood Rev. 20:123-137
12. Fildes, J. E., Yonan, N., and Leonard, C. T. 2008. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance. Transplant. Immunol. 19:1-11
13. Greten, T. F., Manns, M. P., and Korangy, F. 2011. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11: 802-807
14. Hu, P. F., Hultin, L. E., Hultin, P., et al. 1995. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J. AIDS Human Retrovirol. 10:331-340
15. Inagaki, A., Soeda, A., Oka, N., et al. 2007. Long-term maintenance of brain tumor stem cell properties under at non-Adherent and adherent culture conditions. Biochem. Biophys. Res. Commun. 361:586-592
16. Jewett, A., and Bonavida, B. 1994. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNFa and IFNg secretion. Cell. Immunol. 154:273-286
17. Jewett, A., and Bonavida, B. 1995. Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset. Cell. Immunol. 160:91-97
18. Jewett, A., and Bonavida, B. 1996. Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J. Immunol. 156: 907-915
19. Jewett, A., and Bonavida, B. 2000. MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: Role of endogenously-secreted TNFa. Clin. Immunol. 96:19-28
20. Jewett, A., and Tseng H. C. 2013. Tumor microenvironment may shape the function and phenotype of NK cells through theinduction of split anergy and generation of regulatory NK cells. In: The Tumor Immunoenvironment. (Shurin, M., Umansky, V., and Malyguine, A., eds., Eds.). Basel: Springer, pp. 361-384
21. Jewett, A., Arasteh, A., Tseng, H. C., et al. 2010. Strategies to rescue mesenchymal stem cells (MSC) and dental pulp stem cells (DPSC) from NK cell-mediated cytotoxicity. PLoS One 5:e9874
22. Jewett, A., Cacalano, N. A., Head, C., and Teruel, A. 2006a. Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells. Clin. Cancer Res. 12:1994-2003
23. Jewett, A., Cacalano, N. A., Teruel, A., et al. 2006b. Inhibition of NF-kB activity in oral tumor cells prevents depletion of NK cells and increases their functional activation. Cancer Immunol. Immunother. 55: 1052-1063
24. Jewett, A., Cavalcanti, M., and Bonavida, B. 1997. Pivotal role of endogenous TNFa in the induction of functional inactivation and apoptosis in NK cells. J. Immunol. 159:4815-4822
25. Jewett, A., Gan, X. H., Lebow, L. T., and Bonavida, B. 1996. Differential secretion of TNFa and IFNg by human peripheral blood-derived NK subsets and association with functional maturation. J. Clin. Immunol. 16:46-54
26. Jewett, A., Head, C., and Cacalano, N. A. 2006c. Emerging mechanisms of immunosuppression in oral cancers. J. Dent. Res. 85: 1061-1073
27. Jewett, A., Man, Y. G., and Tseng, H. C. 2013. Dual functions of NK cells in selection and differentiation of stem cells: Role in regulation of inflammation and regeneration of tissues. J. Cancer 4:12-24
28. Jewett, A., Teruel, A., Romero, M., et al. 2008. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody. Cancer Immunol. Immunother. 57:1053-1066
29. Jewett, A., Wang, M. Y., Teruel, A., et al. 2003. Cytokine dependent inverse regulation of CD54 (ICAM1) and major histocompatibility complex Class I antigens by NF-kB in HEp2 tumor cell line: Effect on the function of NK cells. Human Immunol. 64:505-520
30. Jiang, B., Mason, J., Jewett, A., et al. 2013a. Tumor-infiltrating immune cells: Triggers for tumor capsule disruption and tumor progression?. Int. J. Med. Sci. 10:475-497
31. Jiang, B., Mason, J., Jewett, A., et al. 2013b. Cell budding from normal appearing epithelia: Predictor of colorectal cancer metastasis?. Int. J. Biol. Sci. 9:119-133
32. Kuss, I., Saito, T., Johnson, J. T., and Whiteside, T. L. 1999. Clinical significance of decreased z chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin. Cancer Res. 5:329-334
33. Lai, P., Rabinowich, H., Crowley-Nowick, P. A., et al. 1996. Alterations in expression and function of signal-transducing proteins in tumorassociated T and NK cells in patients with ovarian carcinoma. Clin. Cancer Res. 2:161-173
34. Man, Y. G., Stojadinovic, A., Mason, J., et al. 2013. Tumor-infiltrating immune cells promoting tumor invasion and metastasis: Existing theories. J. Cancer 4:84-95
35. Mandelboim, O., Malik, P., Davis, D. M., et al. 1999. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc. Natl. Acad. Sci. USA 96:5640-5644
36. Mantovani, A., and Sica, A. 2010. Macrophages, innate immunity and cancer: Balance, tolerance, and diversity. Curr. Opin. Immunol. 22: 231-237
37. Marigo, I., Dolcetti, L., Serafini, P., et al. 2008. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222:162-179
38. Murakami, J., Asaumi, J., Kawai, N., et al. 2005. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer. Cancer Chemother. Pharmacol. 56: 22-28
39. Murakami, J., Asaumi, J., Maki, Y., et al. 2004. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines. Oncol. Rep. 12: 339-345
40. Nemeth, E., Baird, A. W., and O'Farrelly, C. 2009. Microanatomy of the liver immune system. Semin. Immunopathol. 31:333-343
41. Oka, N., Soeda, A., Inagaki, A., et al. 2007. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem. Biophys. Res. Commun. 360:553-559
42. Ortaldo, J. R., Mason, A. T., and O'Shea, J. J. 1995. Receptor-induced death in human natural killer cells: Involvement of CD16. J. Exp. Med. 181:339-344
43. Pasparakis, M., Courtois, G., Hafner, M., et al. 2002. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of Ikk2. Nature 417:861-866
44. Patankar, M. S., Yu, J., Morrison, J. C., et al. 2005. Potent suppression of NK cell response mediated by the ovarian tumor marker CA125. Gynecol. Oncol. 99:704-713
45. Pegram, H. J., Andrews, D. M., Smyth, M. J., et al. 2011. Activating and inhibitory receptors of NK cells. Immunol. Cell. Biol. 89:216-224
46. Rahaman, S. O., Harbor, P. C., Chernova, O., et al. 2002. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21:8404-8413
47. Romagnani, C., Juelke, K., Falco, M., et al. 2007. CD56brightCD16- killer Ig-like receptor NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 178:4947-4955
48. Seitz, C. S., Lin, Q., Deng, H., and Khavari, P. A. 1998. Alterations in NF-kB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kB. Proc. Natl. Acad. Sci. USA 95:2307-2312
49. Sipos, B., Moser, S., Kalthoff, H., et al. 2003. A comprehensive characterization of pancreatic ductal carcinoma cell lines: Towards the establishment of an in vitro research platform. Virchows Arch. 442:444-452
50. Soeda, A., Inagaki, A., Oka, N., et al. 2008. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J. Biol. Chem. 283:10958-10966
51. Squier, C. A., and Kremer, M. J. 2001. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 29:7-15
52. Strowig, T., Chijioke, O., Carrega, P., et al. 2010. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116:4158-4167
53. Tseng, H. C., Arasteh, A., Paranjpe, A., et al. 2010. Increased lysis of stem cells but not their differentiated cells by NK cells: De-differentiation or reprogramming activates NK cells. PLoS One 5:e11590
54. Van Hogerlinden, M., Rozell, B. L., Ahrlund-Richter, L., and Toftgard, R. 1999. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/NF-kB signaling. Cancer Res. 59:3299-3303
55. Van Hogerlinden, M., Rozell, B. L., Toftgard, R., and Sundberg, J. P. 2004. Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kB signaling. J. Invest. Dermatol. 123:101-108
56. Vuk-Pavlovic, S. 2008. Rebuilding immunity in cancer patients. Blood Cells Mol. Dis. 40:94-100
57. Wang, T., G. Niu, G., Kortylewski, M., et al. 2004. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10:48-54
58. Yaguchi, T., Sumimoto, H., Kudo-Saito, C., et al. 2011. Mechanisms of cancer immunoescape and development of overcoming strategies. Int. J. Hematol. 93:294-300
59. Yu, J., W. Du, W., Yan, F., et al. 2013. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph noDe metastasis in patients with breast cancer. J. Immunol. 190:3783-3797